Evidence map›Paper›PMID 36865900›Full record

ArticleGlobal health & medicine2023

Specific COVID-19 risk behaviors and the preventive effect of personal protective equipment among healthcare workers in Japan.

Reiko Shimbashi, Teiichiro Shiino, Akira Ainai, Saya Moriyama, Satoru Arai, Saeko Morino, Sayaka Takanashi, Takeshi Arashiro, Motoi Suzuki, Yukimasa Matsuzawa and 27 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Global health & medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 13 institutions in 1 country.

Reiko ShimbashiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Teiichiro ShiinoCenter for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
Akira AinaiDepartment of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Saya MoriyamaResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Satoru AraiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Saeko MorinoCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Sayaka TakanashiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Takeshi ArashiroCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Motoi SuzukiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Yukimasa MatsuzawaCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Kenichiro KatoNakanoegota Hospital, Nakano, Tokyo, Japan.
Mitsuru HasegawaOkabe Hospital, Kanazawa, Ishikawa, Japan.
Rie KoshidaKanazawa City Health Center, Kanazawa, Ishikawa, Japan.
Masami KitaokaKanazawa City Health Center, Kanazawa, Ishikawa, Japan.
Takafumi UenoFukuoka Kinen Hospital, Fukuoka, Fukuoka, Japan.
Hidefumi ShimizuJCHO Tokyo Shinjuku Medical Center, Shinjuku, Tokyo, Japan.
Hiroyoshi YukiYamada Memorial Hospital, Sumida, Tokyo, Japan.
Tomoko TakedaChuo Public Health Center, Chuo, Tokyo, Japan.
Fukumi Nakamura-UchiyamaTokyo Metropolitan Bokutoh Hospital, Sumida, Tokyo, Japan.
Kashiya TakasugiYoron Tokushukai Hospital, Oshima, Kagoshima, Japan.
Shun IidaDepartment of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Tomoe ShimadaCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Hirofumi KatoDepartment of Virology 1, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Tsuguto FujimotoCenter for Emergency Preparedness and Response, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Naoko Iwata-YoshikawaDepartment of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Kaori SanoDepartment of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Souichi YamadaDepartment of Virology 1, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Yudai KurodaDepartment of Veterinary Science, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Kazu OkumaDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Kiyoko NojimaDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Noriyo NagataDepartment of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Shuetsu FukushiDepartment of Virology 1, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Ken MaedaDepartment of Veterinary Science, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Yoshimasa TakahashiResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Makoto OhnishiDeputy Director-General, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Keiko Tanaka-TayaCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
National Institute of Infectious Diseases · JPChuo University · JPDoai Memorial Hospital · JPFukuoka Kinen Hospital · JPFukuoka Tokushukai Hospital · JPKanazawa Hospital · JPKanazawa Medical Center · JPKanazawa Municipal Hospital · JPKansai Medical University · JPNational Center for Global Health and Medicine · JPNitobe Memorial Nakano General Hospital · JPTokyo Metropolitan Bokutoh Hospital · JPTokyo Yamate Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As coronavirus disease 2019 (COVID-19) outbreaks in healthcare facilities are a serious public health concern, we performed a case-control study to investigate the risk of COVID-19 infection in healthcare workers. We collected data on participants' sociodemographic characteristics, contact behaviors, installation status of personal protective equipment, and polymerase chain reaction testing results. We also collected whole blood and assessed seropositivity using the electrochemiluminescence immunoassay and microneutralization assay. In total, 161 (8.5%) of 1,899 participants were seropositive between August 3 and November 13, 2020. Physical contact (adjusted odds ratio 2.4, 95% confidence interval 1.1-5.6) and aerosol-generating procedures (1.9, 1.1-3.2) were associated with seropositivity. Using goggles (0.2, 0.1-0.5) and N95 masks (0.3, 0.1-0.8) had a preventive effect. Seroprevalence was higher in the outbreak ward (18.6%) than in the COVID-19 dedicated ward (1.4%). Results showed certain specific risk behaviors of COVID-19; proper infection prevention practices reduced these risks.

Indexed as

personal protective equipmentrisk factorsseroepidemiology

Identifiers

PMID36865900
PMCPMC9974228
OpenAlexW4319997564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.